Overview
Xingkai Wang practices practicing medicine in Tianjin, China.
Their clinical expertise encompasses Lung Adenocarcinoma.
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Xingkai Wang
Is Xingkai Wang a top-rated expert for Lung Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Xingkai Wang is classified as an Experienced expert for Lung Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Xingkai Wang participate in research or clinical trials?
Yes. Xingkai Wang has published 33 articles and abstracts on conditions like Lung Adenocarcinoma. You can view a list of Xingkai Wang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers